These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6344313)

  • 1. Cryptogenic fibrosing alveolitis: prediction of fibrogenic activity from immunohistochemical studies of collagen types in lung biopsy specimens.
    Bateman ED; Turner-Warwick M; Haslam PL; Adelmann-Grill BC
    Thorax; 1983 Feb; 38(2):93-101. PubMed ID: 6344313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of types I and III collagen in biopsy lung samples from patients with cryptogenic fibrosing alveolitis.
    Kirk JM; Heard BE; Kerr I; Turner-Warwick M; Laurent GJ
    Coll Relat Res; 1984 May; 4(3):169-82. PubMed ID: 6205817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast chemotactic response elicited by native bronchoalveolar lavage fluid from patients with fibrosing alveolitis.
    Behr J; Adelmann-Grill BC; Krombach F; Beinert T; Schwaiblmair M; Fruhmann G
    Thorax; 1993 Jul; 48(7):736-42. PubMed ID: 8153923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis.
    Egan JJ; Stewart JP; Hasleton PS; Arrand JR; Carroll KB; Woodcock AA
    Thorax; 1995 Dec; 50(12):1234-9. PubMed ID: 8553293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of cryptogenic fibrosing alveolitis.
    Tukiainen P; Taskinen E; Holsti P; Korhola O; Valle M
    Thorax; 1983 May; 38(5):349-55. PubMed ID: 6879483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High resolution computed tomographic assessment of asbestosis and cryptogenic fibrosing alveolitis: a comparative study.
    al-Jarad N; Strickland B; Pearson MC; Rubens MB; Rudd RM
    Thorax; 1992 Aug; 47(8):645-50. PubMed ID: 1412123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.
    Wallace WA; Roberts SN; Caldwell H; Thornton E; Greening AP; Lamb D; Howie SE
    Thorax; 1994 Mar; 49(3):218-24. PubMed ID: 8202877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical importance of the dynamics of the cytological findings in lavage fluid in patients with biopsy-proven cryptogenic fibrosing alveolitis].
    Homolka J; Bohut V; Votava V; Voslárová Z; Zatloukal P
    Cas Lek Cesk; 1988 May; 127(19):589-92. PubMed ID: 3396044
    [No Abstract]   [Full Text] [Related]  

  • 9. Tenascin immunoreactivity in cryptogenic fibrosing alveolitis.
    Wallace WA; Howie SE; Lamb D; Salter DM
    J Pathol; 1995 Apr; 175(4):415-20. PubMed ID: 7540684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
    Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial pulmonary function tests in fibrosing alveolitis.
    Benson MK; Hughes DT
    Br J Dis Chest; 1972 Jan; 66(1):33-44. PubMed ID: 5017931
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunofluorescent staining of lung biopsy in fibrosing alveolitis.
    Poon MC; Epstein SW; Sepp H
    Can Med Assoc J; 1973 Mar; 108(6):734-5 passim. PubMed ID: 4570681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy.
    Haslam PL; Turton CW; Lukoszek A; Salsbury AJ; Dewar A; Collins JV; Turner-Warwick M
    Thorax; 1980 May; 35(5):328-39. PubMed ID: 7434282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of cryptogenic fibrosing alveolitis in three regions of the United Kingdom.
    Johnston ID; Gomm SA; Kalra S; Woodcock AA; Evans CC; Hind CR
    Eur Respir J; 1993 Jun; 6(6):891-3. PubMed ID: 8339811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging and therapy of cryptogenic fibrosing alveolitis.
    Turner-Warwick M
    Chest; 1986 Mar; 89(3 Suppl):148S-150S. PubMed ID: 3948577
    [No Abstract]   [Full Text] [Related]  

  • 16. Accuracy of the typical computed tomographic appearances of fibrosing alveolitis.
    Tung KT; Wells AU; Rubens MB; Kirk JM; du Bois RM; Hansell DM
    Thorax; 1993 Apr; 48(4):334-8. PubMed ID: 8135910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosing alveolitis. Causes, characteristics, and consequences.
    Lillington GA; Siefkin AM
    Postgrad Med; 1982 Apr; 71(4):128-37. PubMed ID: 7071025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT evaluation of fibrosing alveolitis--applications and insights.
    Hansell DM; Wells AU
    J Thorac Imaging; 1996; 11(4):231-49. PubMed ID: 8892193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosing alveolitis.
    Thomas P
    Can Med Assoc J; 1978 Nov; 119(10):1211-6. PubMed ID: 369671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis.
    Wells AU; Hansell DM; Rubens MB; Cullinan P; Black CM; du Bois RM
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1076-82. PubMed ID: 8214928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.